News

Moderna's new lower-dose COVID-19 vaccine approved by FDA
The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...
Researchers discover protein necessary for SARS-CoV-2 to evade the body's defenses
The human body is naturally equipped with defenses to fight off viral infections. For a virus to successfully infect it, it ...
Dr. Carol Fox retires as Independence Health chief medical officer
Dr. Carol Fox can recall a time when patient records existed only on paper. And when a woman who delivered a newborn through ...
Medical Xpress21d
Acute Coronary Syndrome
A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth of plaque in the coronary arteries and an increased risk of ...
CIDRAP3d
1 in 5 COVID survivors still have symptoms 3 years after severe infection, analysis estimates
A meta-analysis of 11 studies suggests that 20% of patients, most with severe COVID-19, had at least one symptom 3 years ...
C&EN6d
Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses
Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, 120 W. Green Street, Athens, Georgia 30602, United States ...